Trial Profile
A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2023
Price :
$35
*
At a glance
- Drugs Anastrozole/levonorgestrel (Primary) ; Leuprorelin; Levonorgestrel
- Indications Endometriosis
- Focus Proof of concept; Therapeutic Use
- Acronyms ESPARIOS 1
- Sponsors Bayer
- 12 Feb 2019 Italy was the planned location as per European Clinical Trials Database record.
- 12 Feb 2019 Results published in the Journal of Clinical Pharmacology
- 02 Nov 2016 Status changed from active, no longer recruiting to completed.